Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer
乔垣结衣
5天前
28
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-07-16 09:49:14 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s00280-014-2505-x
文献链接: http://link.springer.com/10.1007/s00280-014-2505-x
其他信息:
出版社: Springer Science and Business Media LLC
作者: Jun Cao; Jian Zhang; Zhonghua Wang; Biyun Wang; Fangfang Lv; Leiping Wang; Xichun Hu
全文下载地址: http://link.springer.com/content/pdf/10.1007/s00280-014-2505-x.pdf
